⚗️ biochemistry

Mapping the chaperonin TRiC/CCT interactome in mouse photoreceptors reveals functional significance for energy metabolism

This study maps the TRiC/CCT chaperonin interactome in mouse rod photoreceptors to reveal that TRiC dysfunction triggers a metabolic energy crisis and proteostasis imbalance, ultimately driving neurodegeneration through disrupted glucose uptake and substrate overload.

Original authors: Brooks, C., Salcedo Tacuma, D., Mascari, I., Eminhizer, M., Ngo, T., Kolson, D., Sechrest, E., Guan, T., Billington, N., Deng, W. T., Smith, D., Du, J., Skiba, N., Sokolov, M.

Published 2026-03-15

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Brooks, C., Salcedo Tacuma, D., Mascari, I., Eminhizer, M., Ngo, T., Kolson, D., Sechrest, E., Guan, T., Billington, N., Deng, W. T., Smith, D., Du, J., Skiba, N., Sokolov, M.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Big Picture: The Eye's "Quality Control" Team

Imagine your eye's rod cells (the parts that let you see in the dark) as a high-speed, 24/7 factory. This factory is incredibly busy, constantly building new parts to keep the factory running. But building complex machines requires a special team of helpers to make sure every piece is assembled correctly. If a piece is built wrong, it can jam the whole machine.

In biology, this helper team is called TRiC (or CCT). Think of TRiC as a giant, ring-shaped folding machine inside the cell. Its job is to take raw, floppy proteins and fold them into their perfect, working shapes. Without TRiC, the factory stops, and the cell dies.

This study asked two big questions:

Who does TRiC help? (What are all the different parts it folds?)
What happens if TRiC breaks? (How does the factory fail?)

Part 1: Mapping the "Help List" (The Interactome)

To find out who TRiC helps, the scientists created a special mouse. They gave the mouse a "tag" (like a bright neon sticker) on one of the TRiC machine parts. This allowed them to use a magnet to pull the entire TRiC machine out of the eye tissue and see what else was stuck to it.

The Discovery:
They found 226 different proteins that hang out with TRiC.

The Usual Suspects: They found the famous ones they already knew, like Tubulin (the steel beams that build the cell's skeleton) and Transducin (the signal messengers that tell the brain "I see light!").
The New Stars: They found many new helpers involved in energy production (making fuel for the cell) and RNA processing (the instructions for building proteins).

The Analogy:
Imagine you pull a magnet out of a busy workshop and find 226 different tools stuck to it. You realize the machine doesn't just fix the big steel beams; it also fixes the fuel pumps, the blueprints, and the delivery trucks.

Part 2: The "Energy Crisis" (What happens when TRiC breaks)

To see what happens when TRiC stops working, the scientists used a "saboteur" protein called PhLPs. Think of PhLPs as a glitchy robot that jams itself into the TRiC machine. It sits in the machine, blocking the door so no other proteins can get in to be folded.

The Result:
When the TRiC machine was jammed, the rod cells didn't just stop making vision proteins; they ran out of energy.

The Metabolic Crash: The scientists found that the cells had very low levels of ATP (the cell's battery), NAD (the fuel for the battery), and sugars.
The "Energy Crisis": It was like the factory's power plant had exploded. The cells couldn't burn sugar or fat for fuel anymore.

The Surprise:
Usually, when eye cells die (like in other eye diseases), they show different signs. But when TRiC breaks, the specific sign is a total energy collapse. It's as if the factory didn't just stop making products; the lights went out, the heating stopped, and the delivery trucks couldn't start.

The Culprit:
The study found that a protein called Rab10 (a traffic cop for glucose delivery) was messed up. Because Rab10 wasn't folded correctly by TRiC, it couldn't bring sugar (glucose) into the cell. No sugar in = No energy = Cell death.

Part 3: The "Traffic Jam" Theory (Substrate Overload)

The researchers also tested what happens if one specific protein gets stuck in a "broken" shape. They created a mutant version of a protein called Gβ1 that couldn't fold properly.

The Analogy:
Imagine the TRiC machine is a single-lane tunnel. Normally, cars (proteins) drive through quickly. But if one car breaks down and gets stuck in the middle of the tunnel, no other cars can get through.

The Finding:
When this broken Gβ1 protein got stuck in the TRiC tunnel, it blocked the machine from helping other essential proteins (like the steel beams/Tubulin).

The Domino Effect: One broken part didn't just ruin itself; it clogged the whole system, causing the steel beams to collapse and the energy pumps to fail. This explains why a single mutation can lead to total blindness.

Summary: Why This Matters

This paper tells us that TRiC is more than just a "protein folder." It is the guardian of the cell's energy supply.

It's a Master Helper: It folds a huge variety of parts, from structural beams to fuel pumps.
Energy is Key: If TRiC fails, the cell doesn't just lose its structure; it loses its power source (glucose and mitochondria).
One Bad Apple: If one protein gets stuck in the TRiC machine, it can block the whole factory, leading to a rapid "energy crisis" and cell death.

The Takeaway:
This research suggests that to save eyes from degeneration, we might need to look beyond just fixing the broken vision proteins. We might need to boost the energy supply or clear the traffic jams in the TRiC machine to keep the factory running.

1. Problem Statement

The eukaryotic chaperonin TRiC/CCT (TCP-1 ring complex) is essential for folding ~10% of cytosolic proteins, including those with complex structures like $\beta$ -propellers and $\alpha/\beta$ -barrels. While TRiC is known to be critical for neuronal health and its dysfunction is linked to neurodegenerative diseases (e.g., Alzheimer's, Huntington's) and retinal dystrophies (e.g., Leber congenital amaurosis), its specific interactome and functional roles within rod photoreceptors remain poorly defined. Rods have unique high metabolic demands and rely on continuous protein turnover for outer segment renewal. The study aims to:

Map the in vivo TRiC interactome in mammalian rods.
Determine the consequences of TRiC loss-of-function on the retinal proteome and metabolome.
Investigate the mechanism by which misfolded substrates might exacerbate proteostasis imbalance and neurodegeneration.

2. Methodology

The researchers employed a multi-omics approach combining genetic engineering, affinity purification, mass spectrometry, and metabolomics.

Generation of TRiCet Mice: A transgenic mouse line was created expressing an epitope-tagged Tcp-1 $\alpha$ subunit (FLAG-HA tag) driven by the rod-specific rhodopsin promoter. This allowed for the affinity purification of intact TRiC complexes from retinal tissue without overexpression artifacts.
Loss-of-Function Models:
- PhLPs Model: Expression of a short splice isoform of Phosducin-like protein (PhLPs), which competitively inhibits TRiC activity by binding it without facilitating substrate folding.
- Substrate Overload Models:
  - In vitro: Expression of a perpetually unfolded G $\beta$ 1 mutant (G $\beta$ 1AA) that cannot dimerize with G $\gamma$ 1.
  - In vivo: Crossing TRiCet mice with G $\gamma$ 1-knockout mice to create a genetic model of unfolded G $\beta$ 1 accumulation.
Proteomics:
- Affinity Purification: TRiC complexes were purified from retinas using anti-FLAG beads.
- Mass Spectrometry: Two orthogonal approaches were used: DDA (Data-Dependent Acquisition) and DIA (Data-Independent Acquisition) to identify TRiC-interacting proteins.
- TMT-MS (Tandem Mass Tag): Used to quantify global proteomic changes in PhLPs mice at postnatal days 14 (P14) and 18 (P18) compared to wild-type controls.
Metabolomics: Targeted LC-MS was performed on retinal extracts to profile metabolites (glycolysis, TCA cycle, fatty acid oxidation, nucleotides) in PhLPs mice, wild-type controls, and Rho P23H mice (a disease control for retinal degeneration).
Multi-Omics Integration: DIABLO (Data Integration Analysis for Biomarker discovery using Latent cOmponents) was used to correlate proteomic and metabolomic datasets to identify drivers of metabolic dysregulation.
Validation: Techniques included Western blotting, Native PAGE, Transmission Electron Microscopy (TEM), Immunofluorescence, and Electroretinography (ERG).

3. Key Contributions

First In Vivo TRiC Interactome in Rods: The study provides a comprehensive map of 226 TRiC-interacting proteins in mouse rod photoreceptors, identifying both known substrates (tubulins, transducin subunits) and novel candidates involved in RNA processing, cytoskeletal organization, and cell-cycle regulation.
Discovery of a Metabolic "Energy Crisis": The study establishes a direct link between TRiC dysfunction and a collapse in energy metabolism, distinct from general retinal degeneration.
Mechanism of Substrate Competition: The paper demonstrates that an accumulation of a single misfolded substrate (unfolded G $\beta$ 1) can sequester TRiC, competitively displacing other essential clients and causing global proteostasis failure.
Identification of Rab10/GLUT4 Axis: Integrated analysis identified Rab10 as a key driver linking TRiC dysfunction to impaired glucose uptake via defective GLUT4 trafficking.

4. Key Results

A. TRiC Interactome Characterization

226 Interactors: Mass spectrometry identified 226 proteins enriched in the TRiC complex.
Structural Features: ~60% of interactors were <60 kDa. Common structural motifs included RNA recognition motifs and $\beta$ -propeller folds.
Functional Categories: Interactors were enriched in RNA processing, cytoskeletal organization, and cell-cycle regulation.
Validation: Known substrates (Tubulins, G $\beta$ 1, G $\beta$ 5) and co-chaperones (Phosducin-like proteins) were confirmed.

B. Proteomic Changes in TRiC Loss-of-Function (PhLPs Model)

Early Stage (P14): Significant reduction in canonical TRiC substrates, particularly tubulins (Tubb5, Tubb4a, etc.) and transducin $\beta$ subunits. This correlates with the arrest of rod outer segment (ROS) development, which is microtubule-dependent.
Late Stage (P18): Widespread secondary effects. Reductions in:
- Energy Metabolism Enzymes: Triosephosphate isomerase (Tpi1), Uridine-cytidine kinase-like 1 (Uckl1).
- Downstream Proteins: Glycolytic enzymes (Gapdh, Pkm), TCA cycle components, and mitochondrial proteins.
- Trafficking: Rab10, Snap25, Anxa1.
Compensatory Responses: Upregulation of proteostasis machinery (proteasome subunits, heat shock proteins) and chromatin remodeling factors.

C. Metabolomic "Energy Crisis"

Distinct Signature: PhLPs retinas showed a severe depletion of ATP, NAD, NADH, glycolytic intermediates, TCA cycle metabolites, and acylcarnitines.
Comparison with Rho P23H: Unlike the Rho P23H model (which showed elevated amino acids and methylation intermediates typical of stress responses), the PhLPs model exhibited a specific collapse of energy production (glycolysis, TCA, fatty acid oxidation).
Implication: TRiC deficiency causes a primary metabolic failure, not just a secondary consequence of cell death.

D. Multi-Omics Integration (DIABLO)

Rab10-GLUT4 Axis: Integration revealed a strong correlation between Rab10 abundance and glucose levels. This suggests that TRiC dysfunction destabilizes Rab10, leading to defective GLUT4 trafficking and impaired glucose uptake, driving the energy crisis.
Anxa1: Linked to aminoadipic acid, suggesting a potential role in amino acid homeostasis.

E. Substrate Overload Mechanism

Competition: In G $\gamma$ 1-knockout mice (or cells expressing G $\beta$ 1AA), the unfolded G $\beta$ 1 accumulates and binds TRiC with high affinity (2.2-fold increase).
Displacement: This sequestration displaces other essential substrates (e.g., tubulins, Atg16l1), leading to cytoskeletal instability and impaired autophagy.
Cytotoxicity: This "substrate dominance" mechanism explains how specific folding mutations can trigger global cellular collapse.

5. Significance

Novel Pathogenic Mechanism: The study reveals that TRiC dysfunction in photoreceptors leads to a specific metabolic collapse (energy crisis) distinct from other forms of retinal degeneration. This highlights a vulnerability where proteostasis failure directly compromises bioenergetics.
Therapeutic Targets: The identification of Rab10 and the GLUT4 trafficking pathway as critical nodes connecting chaperone failure to metabolic failure offers new potential therapeutic targets for retinal dystrophies.
General Neurodegeneration Principle: The finding that a single misfolded substrate can sequester TRiC and displace other clients provides a unifying mechanism for how specific mutations in chaperone clients (like those in actin or tubulin) can lead to widespread proteostasis imbalance and neurodegeneration.
BBSome Connection: The study supports the hypothesis that TRiC dysfunction contributes to Bardet-Biedl Syndrome (BBS) pathology by destabilizing BBSome components (specifically Bbs1) and the cytoskeleton.

In conclusion, this work provides the first in vivo map of the TRiC interactome in rods, demonstrating that TRiC is a linchpin for both structural integrity and metabolic health in photoreceptors, and that its failure triggers a cascade of proteostasis and energy collapse leading to neurodegeneration.